Invivyd, Inc. — All Filings
407 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
3/A
4
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFA14C
DEFC14A
DEFC14C
DFAN14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
PREC14A
PREC14C
PRER14C
PRRN14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 SUBMISSION | 0000899243-22-025328 | Jul 6, 2022 | Jul 5, 2022 |
| 8-K | 8-K | 0001193125-22-187977 | Jul 5, 2022 | Jul 1, 2022 |
| SC 13D/A | SC 13D/A | 0001193125-22-187564 | Jul 5, 2022 | — |
| 8-K | 8-K | 0001193125-22-186218 | Jun 30, 2022 | Jun 24, 2022 |
| SC 13D/A | SC 13D/A | 0001193125-22-181642 | Jun 24, 2022 | — |
| SC 13D/A | SCHEDULE 13D (AMENDMENT NO. 2) | 0000914121-22-004040 | Jun 24, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-22-024047 | Jun 24, 2022 | Jun 22, 2022 |
| SC 13D/A | SC 13D/A | 0001193125-22-181609 | Jun 24, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-22-181596 | Jun 24, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-22-024027 | Jun 24, 2022 | Jun 22, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-024021 | Jun 24, 2022 | Jun 22, 2022 |
| 3 | FORM 3 SUBMISSION | 0000899243-22-024018 | Jun 24, 2022 | Jun 22, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-024015 | Jun 24, 2022 | Jun 22, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-024012 | Jun 24, 2022 | Jun 22, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-023996 | Jun 24, 2022 | Jun 22, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-023984 | Jun 24, 2022 | Jun 22, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-023969 | Jun 24, 2022 | Jun 22, 2022 |
| SC 13D/A | ADAGIO THERAPEUTICS, INC. | 0000902664-22-003399 | Jun 24, 2022 | — |
| 8-K | 8-K | 0001193125-22-178882 | Jun 22, 2022 | — |
| DEFA14C | DEFA14C | 0001193125-22-177782 | Jun 21, 2022 | — |
| 8-K | 8-K | 0001193125-22-177777 | Jun 21, 2022 | Jun 17, 2022 |
| DFAN14A | DFAN14A | 0001193125-22-167561 | Jun 6, 2022 | — |
| DEFC14C | DEFC14C | 0001193125-22-166247 | Jun 2, 2022 | — |
| CORRESP | — | 0001193125-22-164093 | May 31, 2022 | — |
| PRER14C | PRER14C | 0001193125-22-164089 | May 31, 2022 | — |
| UPLOAD | — | 0000000000-22-005843 | May 27, 2022 | — |
| DEFA14C | DEFA14C | 0001193125-22-155177 | May 19, 2022 | — |
| 8-K | 8-K | 0001193125-22-155156 | May 19, 2022 | — |
| PREC14C | PREC14C | 0001193125-22-155139 | May 19, 2022 | — |
| S-8 | S-8 | 0001193125-22-149581 | May 13, 2022 | — |
| 10-Q | 10-Q | 0000950170-22-009799 | May 13, 2022 | Mar 31, 2022 |
| 8-K | 8-K | 0001193125-22-149345 | May 13, 2022 | — |
| 10-K/A | 10-K/A | 0001193125-22-134035 | Apr 29, 2022 | Dec 31, 2021 |
| DEFC14A | DEFC14A | 0001193125-22-133527 | Apr 29, 2022 | — |
| PRRN14A | PRRN14A | 0001193125-22-122799 | Apr 27, 2022 | — |
| SC 13D/A | ADAGIO THERAPEUTICS, INC. | 0000902664-22-002675 | Apr 26, 2022 | — |
| PREC14A | PREC14A | 0001193125-22-118162 | Apr 26, 2022 | — |
| SC 13D/A | SCHEDULE 13D (AMENDMENT NO. 1) | 0000914121-22-003216 | Apr 26, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-22-118343 | Apr 26, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-22-118329 | Apr 26, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-22-118250 | Apr 26, 2022 | — |
| PRRN14A | PRRN14A | 0001193125-22-117915 | Apr 25, 2022 | — |
| UPLOAD | — | 0000000000-22-004153 | Apr 18, 2022 | — |
| PREC14A | PREC14A | 0001193125-22-100921 | Apr 11, 2022 | — |
| SC 13D | SCHEDULE 13D | 0000914121-22-002824 | Apr 7, 2022 | — |
| 3/A | FORM 3/A | 0001567619-22-008202 | Apr 6, 2022 | Mar 28, 2022 |
| 3 | — | 0000902664-22-002394 | Apr 1, 2022 | Mar 28, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-013098 | Apr 1, 2022 | Mar 3, 2022 |
| SC 13D | ADAGIO THERAPEUTICS, INC. | 0000902664-22-002385 | Apr 1, 2022 | — |
| 10-K | 10-K | 0000950170-22-005112 | Mar 31, 2022 | Dec 31, 2021 |